Abiopharma

🔍 Cusack Catherine (Director)

Company: Sabra Health Care REIT, Inc. (SBRA)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 791 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 82,847.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
• F2: Includes 7,027 unvested stock units and 47,553 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.